Clark Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$907K Sell
756
-34
-4% -$34.7K 0.07% 105
2026
Q1
$727K Buy
790
+45
+6% +$45.6K 0.07% 100
2025
Q4
$801K Buy
745
+7
+0.9% +$6.69K 0.08% 86
2025
Q3
$563K Buy
738
+76
+11% +$56.6K 0.07% 112
2025
Q2
$516K Buy
662
+46
+7% +$35.7K 0.07% 105
2025
Q1
$509K Buy
616
+160
+35% +$133K 0.09% 82
2024
Q4
$352K Sell
456
-195
-30% -$161K 0.07% 89
2024
Q3
$577K Buy
651
+185
+40% +$166K 0.12% 64
2024
Q2
$422K Buy
+466
New +$373K 0.12% 66

Other funds holding LLY

Clark Asset Management's LLY Position: Q2 2026 in Review

Clark Asset Management reduced its Eli Lilly (LLY) stake by 4.3% in Q2 2026, selling an estimated $34.7K and leaving 756 shares worth $907K. The position accounts for 0.07% of the portfolio, ranked #105.

Clark Asset Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clark Asset Management held 756 shares of Eli Lilly worth $907K as of Q2 2026.
  • Clark Asset Management sold 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 0.07% of Clark Asset Management's portfolio in Q2 2026, its #105 holding.
  • Clark Asset Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clark Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.